Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
26.27
-0.11 (-0.42%)
Sep 24, 2026, 4:00 PM EDT - Market closed
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $3.3 billion as of September 24, 2026. Its market cap has increased by 56.47% in one year.
Market Cap
3.30B
Enterprise Value
3.18B
1-Year Change
56.47%
Ranking
Category
Stock Price
$26.27
ChartMarket Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $3.30B, an increase of 322.22%. That is a compound annual growth rate of 24.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 3.30B | -7.18% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 3.88B |
| IDEAYA Biosciences | 3.83B |
| Xenon Pharmaceuticals | 3.79B |
| Legend Biotech | 3.61B |
| Enliven Therapeutics | 3.53B |
| Denali Therapeutics | 3.45B |
| Arcus Biosciences | 3.42B |
| Tarsus Pharmaceuticals | 3.38B |